Cetera Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Cetera Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,006	Closed	-$218K	–	1372
2021 Q1	$218K	Buy	+1,006	New	+$189K	0.01%	1112
2019 Q3	–	Sell	-1,696	Closed	-$293K	–	987
2019 Q2	$293K	Buy	1,696 +58	+4%	+$10K	0.01%	710
2019 Q1	$277K	Buy	+1,638	New	+$244K	0.01%	662
2018 Q4	–	Sell	-3,360	Closed	-$584K	–	998
2018 Q3	$584K	Sell	3,360 -583	-15%	-$84.1K	0.03%	507
2018 Q2	$550K	Buy	+3,943	New	+$560K	0.03%	485

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Cetera Advisors's GWPH Position: Q2 2021 in Review

Cetera Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 1,006 shares — an estimated $218K sold.

Cetera Advisors first reported a position in GWPH in Q2 2018 and held it in 5 quarters. The position peaked at $584K in Q3 2018. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Cetera Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Cetera Advisors sold 1,006 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $218K.
Cetera Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2018 and held it in 5 quarters.
Cetera Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $584K in Q3 2018.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Cetera Advisors's 13F filing for Q2 2021, filed 13 Aug 2021.